Intraductal Papillary Mucinous Neoplasm With Malignant Change
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02044926|
Recruitment Status : Terminated (Because patient enrollment is so difficult.)
First Posted : January 24, 2014
Last Update Posted : July 22, 2016
To investigate diagnostic performance of CT and MR in intraductal papillary mucinous neoplasm with malignant change according to international consensus guidelines 2012.
Hypothesis: According to 2012 consensus guidelines, enhanced solid component and main pancreatic duct size of larger than 10 mm will be significant.
|Condition or disease|
- To investigate diagnostic performance of CT and MR in intraductal papillary mucinous neoplasm with malignant change according to international consensus guidelines 2012
- Patient who is suspected to have pancreas IPMN on imaging
- Interval between imaging study and surgery is less than 2 months
- Who is scheduled for surgery due to IPMN
|Study Type :||Observational|
|Actual Enrollment :||54 participants|
|Official Title:||Intraductal Papillary Mucinous Neoplasm (IPMN) With Malignant Change: Prospective Study to Assess Diagnostic Performance of CT and Magnetic Resonance Imaging (MR) According to International Consensus Guidelines 2012|
|Study Start Date :||January 2014|
|Actual Primary Completion Date :||May 2016|
|Actual Study Completion Date :||July 2016|
- Imaging predictor of malignant IPMN of the pancreas [ Time Frame: one month ]We will assess baseline CT and MRI findings of patients within one month after surgery.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02044926
|Korea, Republic of|
|Asan Medical Center|
|Seoul, Korea, Republic of|
|Principal Investigator:||Jae Ho Byun||Asan Medical Center|